Regeneron Pharmaceuticals Inc (REGN)
744.42
+1.07
(+0.14%)
USD |
NASDAQ |
Nov 21, 16:00
746.00
+1.58
(+0.21%)
After-Hours: 16:42
Regeneron Pharmaceuticals Price to Book Value: 2.790 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.786 |
| November 19, 2024 | 2.790 |
| November 18, 2024 | 2.855 |
| November 15, 2024 | 2.836 |
| November 14, 2024 | 2.932 |
| November 13, 2024 | 3.014 |
| November 12, 2024 | 3.076 |
| November 11, 2024 | 3.094 |
| November 08, 2024 | 3.104 |
| November 07, 2024 | 3.090 |
| November 06, 2024 | 3.060 |
| November 05, 2024 | 3.108 |
| November 04, 2024 | 3.106 |
| November 01, 2024 | 3.161 |
| October 31, 2024 | 3.141 |
| October 30, 2024 | 3.458 |
| October 29, 2024 | 3.475 |
| October 28, 2024 | 3.480 |
| October 25, 2024 | 3.496 |
| October 24, 2024 | 3.481 |
| October 23, 2024 | 3.528 |
| October 22, 2024 | 3.614 |
| October 21, 2024 | 3.637 |
| October 18, 2024 | 3.720 |
| October 17, 2024 | 3.748 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.785 |
| October 15, 2024 | 3.817 |
| October 14, 2024 | 3.808 |
| October 11, 2024 | 3.814 |
| October 10, 2024 | 3.751 |
| October 09, 2024 | 3.801 |
| October 08, 2024 | 3.775 |
| October 07, 2024 | 3.740 |
| October 04, 2024 | 3.803 |
| October 03, 2024 | 3.810 |
| October 02, 2024 | 3.906 |
| October 01, 2024 | 3.931 |
| September 30, 2024 | 3.947 |
| September 27, 2024 | 4.075 |
| September 26, 2024 | 4.064 |
| September 25, 2024 | 4.03 |
| September 24, 2024 | 4.088 |
| September 23, 2024 | 4.268 |
| September 20, 2024 | 4.475 |
| September 19, 2024 | 4.495 |
| September 18, 2024 | 4.451 |
| September 17, 2024 | 4.482 |
| September 16, 2024 | 4.506 |
| September 13, 2024 | 4.508 |
| September 12, 2024 | 4.551 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.786
Minimum
Nov 20 2024
7.705
Maximum
Jul 20 2020
4.204
Average
3.913
Median
May 06 2024
Price to Book Value Benchmarks
| Amgen Inc | 20.70 |
| Eli Lilly and Co | 49.99 |
| Pfizer Inc | 1.543 |
| Biogen Inc | 1.406 |
| AbbVie Inc | 50.30 |
Price to Book Value Related Metrics
| PE Ratio | 18.42 |
| PS Ratio | 6.188 |
| PEG Ratio | 1.207 |
| Price to Free Cash Flow | 25.81 |
| Price | 744.42 |
| Earnings Yield | 5.43% |
| Market Cap | 81.80B |
| PEGY Ratio | 1.207 |
| Operating PE Ratio | 20.95 |
| Normalized PE Ratio | 19.44 |